| http://purl.uniprot.org/citations/38312840 | http://www.w3.org/1999/02/22-rdf-syntax-ns#type | http://purl.uniprot.org/core/Journal_Citation |
| http://purl.uniprot.org/citations/38312840 | http://www.w3.org/2000/01/rdf-schema#comment | "PSME3 plays a significant role in tumor progression. However, the prognostic value of PSME3 in pan-cancer and its involvement in tumor immunity remain unclear. We conducted a comprehensive study utilizing extensive RNA sequencing data from the TCGA (The Cancer Genome Atlas) and GTEx (Genotype-Tissue Expression) databases. Our research revealed abnormal expression levels of PSME3 in various cancer types and unveiled a correlation between high PSME3 expression and adverse clinical outcomes, especially in cancers like liver cancer (LIHC) and lung adenocarcinoma (LUAD). Functional enrichment analysis highlighted multiple biological functions of PSME3, including its involvement in protein degradation, immune responses, and stem cell regulation. Moreover, PSME3 showed associations with immune infiltration and immune cells in the tumor microenvironment, indicating its potential role in shaping the cancer immune landscape. The study also unveiled connections between PSME3 and immune checkpoint expression, with experimental validation demonstrating that PSME3 positively regulates CD276. This suggests that PSME3 could be a potential therapeutic target in immunotherapy. Additionally, we predicted sensitive drugs targeting PSME3. Finally, we confirmed in both single-factor Cox and multiple-factor Cox regression analyses that PSME3 is an independent prognostic factor. We also conducted preliminary validations of the impact of PSME3 on cell proliferation and wound healing in liver cancer. In summary, our study reveals the multifaceted role of PSME3 in cancer biology, immune regulation, and clinical outcomes, providing crucial insights for personalized cancer treatment strategies and the development of immunotherapy."xsd:string |
| http://purl.uniprot.org/citations/38312840 | http://purl.org/dc/terms/identifier | "doi:10.3389/fimmu.2024.1295693"xsd:string |
| http://purl.uniprot.org/citations/38312840 | http://purl.uniprot.org/core/author | "Guo Y."xsd:string |
| http://purl.uniprot.org/citations/38312840 | http://purl.uniprot.org/core/author | "Ge X."xsd:string |
| http://purl.uniprot.org/citations/38312840 | http://purl.uniprot.org/core/author | "Yang Y."xsd:string |
| http://purl.uniprot.org/citations/38312840 | http://purl.uniprot.org/core/author | "Dong C."xsd:string |
| http://purl.uniprot.org/citations/38312840 | http://purl.uniprot.org/core/date | "2024"xsd:gYear |
| http://purl.uniprot.org/citations/38312840 | http://purl.uniprot.org/core/name | "Front Immunol"xsd:string |
| http://purl.uniprot.org/citations/38312840 | http://purl.uniprot.org/core/pages | "1295693"xsd:string |
| http://purl.uniprot.org/citations/38312840 | http://purl.uniprot.org/core/title | "Comprehensive analysis of PSME3: from pan-cancer analysis to experimental validation."xsd:string |
| http://purl.uniprot.org/citations/38312840 | http://purl.uniprot.org/core/volume | "15"xsd:string |
| http://purl.uniprot.org/citations/38312840 | http://www.w3.org/2004/02/skos/core#exactMatch | http://purl.uniprot.org/pubmed/38312840 |
| http://purl.uniprot.org/citations/38312840 | http://xmlns.com/foaf/0.1/primaryTopicOf | https://pubmed.ncbi.nlm.nih.gov/38312840 |
| http://purl.uniprot.org/uniprot/#_B7Z8D3-mappedCitation-38312840 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/38312840 |
| http://purl.uniprot.org/uniprot/#_B3KQ25-mappedCitation-38312840 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/38312840 |
| http://purl.uniprot.org/uniprot/#_J7FRP4-mappedCitation-38312840 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/38312840 |
| http://purl.uniprot.org/uniprot/#_K9J957-mappedCitation-38312840 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/38312840 |
| http://purl.uniprot.org/uniprot/#_P61289-mappedCitation-38312840 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/38312840 |
| http://purl.uniprot.org/uniprot/#_Q6FHK7-mappedCitation-38312840 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/38312840 |
| http://purl.uniprot.org/uniprot/#_Q6MZZ1-mappedCitation-38312840 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/38312840 |
| http://purl.uniprot.org/uniprot/#_V9HWJ8-mappedCitation-38312840 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/38312840 |
| http://purl.uniprot.org/uniprot/B7Z8D3 | http://purl.uniprot.org/core/mappedCitation | http://purl.uniprot.org/citations/38312840 |
| http://purl.uniprot.org/uniprot/K9J957 | http://purl.uniprot.org/core/mappedCitation | http://purl.uniprot.org/citations/38312840 |
| http://purl.uniprot.org/uniprot/J7FRP4 | http://purl.uniprot.org/core/mappedCitation | http://purl.uniprot.org/citations/38312840 |